Get medically-vetted reviews on pricing, insurance coverage, and real-world weight loss results — so you can find the right program for your body and your budget.
As a dedicated GLP-1 consumer advocate, we review every program independently — no provider pays for rankings or placement. Medical review by licensed healthcare professionals.
Our 2026 Verdict
Based on independent scoring across 5 criteria — updated March 2026. In 2026, our data indicates Ro Body is the best all-around for insurance navigation, while Hims & Hers remains the top choice for budget-conscious patients.
Best for insurance navigation and clinical support. Ro Body’s care team actively works with your insurer to maximize coverage — making branded semaglutide or tirzepatide accessible at the lowest realistic out-of-pocket cost.
Read our full 2026 Ro Body Review →Best for cost-conscious patients. Hims & Hers offers the most affordable monthly starting price among major GLP-1 providers, with flexible plans and no mandatory coaching add-ons.
Read our full 2026 Hims & Hers Review →Best for comprehensive lifestyle support. Calibrate pairs GLP-1 medication with dedicated one-on-one health coaching — the strongest choice for patients who want structured behavioral guidance alongside medication.
Read our full 2026 Calibrate Review →Not sure which fits you? Take our 2-minute quiz for a personalized recommendation →
📰 Latest GLP-1 News
FDA Grants Priority Review to Oral Semaglutide NDA for Obesity
Novo Nordisk's oral semaglutide NDA for obesity treatment receives FDA priority review with a PDUFA date of August 2026.
Read full story →GLP-1 Medications Linked to 34% Reduction in Cardiovascular Events
Large-scale outcomes trial finds GLP-1 receptor agonists significantly reduce major adverse cardiovascular events vs. placebo.
Read full story →Medicare Confirms GLP-1 Coverage Expansion for Obesity — July 2026
CMS announces 3.4 million Medicare beneficiaries will gain GLP-1 coverage starting July 1, 2026 under Part D.
Read full story →News summaries are generated by our editorial team and AI. Always read the full source article before making health decisions. View full archive →
Why Trust Us
GLP1Authority was founded on a simple principle: people making serious health decisions deserve honest information, not content shaped by ad budgets.
We review GLP-1 telehealth programs the same way a consumer watchdog would — evaluating clinical evidence, pricing transparency, program design, and real patient outcomes. No provider pays for a better rating. No brand partner can influence our scores.
Our editorial team includes licensed physicians and registered dietitians who review all health claims before publication.
Our Scoring Methodology
Every provider review on GLP1Authority uses the same 5-part scoring framework — because the right program depends on your insurance, your health goals, and what you can afford. Each criterion is weighted based on its real-world importance to patient outcomes and value.
| Criterion | Weight | What We Evaluate |
|---|---|---|
| Clinical Effectiveness | 30% | Published outcomes data, FDA approval status, clinical trial evidence, and provider-reported weight loss results |
| Cost & Transparency | 25% | Total monthly cost (including medication), hidden fees, pricing clarity, refund policies, cancellation terms |
| Program Comprehensiveness | 20% | Coaching, behavioral support, dietary guidance, lab work, medication breadth, care team access |
| Accessibility & Convenience | 15% | State availability, telehealth experience, app/platform quality, prescription turnaround time |
| Customer Satisfaction | 10% | Verified patient reviews, BBB rating, refund disputes, social media sentiment, 3rd-party ratings |
No provider has paid GLP1Authority to appear on this page or to receive a higher score. Our rankings are 100% data-driven — calculated using the same 5-part framework applied equally to every program we evaluate. See our full methodology →
How the top telehealth GLP-1 providers compare on the factors that matter most to patients.
Prices reflect estimated monthly cost including medication. Insurance savings vary. Last updated March 2026. See our full methodology →
GLP-1 receptor agonists are a class of injectable (and now oral) medications originally developed to treat Type 2 diabetes. In clinical trials, they produced dramatic weight loss when used for chronic weight management in patients with obesity.
| Medication | Brand Names | Avg. Weight Loss | Form |
|---|---|---|---|
| Semaglutide | Wegovy, Ozempic | ~15% body weight | Weekly injection |
| Tirzepatide | Zepbound, Mounjaro | ~20-22% body weight | Weekly injection |
| Oral Semaglutide | Rybelsus (diabetes), compounded forms | ~9-10% body weight | Daily pill |
| Compounded variants | Various brand names vary by provider | Results vary | Injection or pill |
Compounded semaglutide and tirzepatide are not FDA-approved versions of Wegovy, Ozempic, Zepbound, or Mounjaro. They may be prescribed legally when brand-name medications are on the FDA shortage list. As of early 2026, brand-name shortages have eased significantly, which may affect the legal status of compounded versions. Always verify with your provider.
BMI 30+ OR BMI 27+ with a weight-related condition (Type 2 diabetes, high blood pressure, etc.)
We spent hundreds of hours evaluating nine of the leading GLP-1 telehealth programs.
Best for insurance users. Highest long-term weight loss data (19% over 3 years). Enterprise-grade care team. Now focuses on employer programs — individual access may be limited.
Read Full Review →Best all-around for new patients. Strong insurance concierge, RN health coaching, and brand-name medication access. Premium price but comprehensive support.
Read Full Review →Best for medication flexibility. 10+ medications including non-GLP-1 options. MetabolicPrint assessment tailors treatment. Most affordable tier starts at $99/mo.
Read Full Review →Best for low-cost entry. $69-$99/mo is the most affordable option. However, compounded pill discontinued Feb 2026 due to FDA pressure. No structured coaching.
Read Full Review →Best for cash-pay patients seeking compounded options. Transparent pricing, dedicated care team, but compounded-only offering and limited state availability (44 states).
Read Full Review →Best for multiple formulation options — offers both injectable and dissolvable tablet forms for semaglutide and tirzepatide. Fast approval, 24/7 care team, and a results guarantee.
Read Full Review →Best budget pick with three formulation types (injectable, sublingual, oral tablet). Starting at $199/mo with free overnight shipping, unlimited consultations, and all 50 states covered.
Read Full Review →Price-lock guarantee keeps your rate fixed even as doses escalate. All-inclusive semaglutide from $179/mo with 600+ board-certified physicians and a 4.9-star Trustpilot rating.
Read Full Review →Flat-rate pricing with a price-lock guarantee and a 10% weight loss in 4 months or money-back guarantee. Semaglutide from $299/mo, tirzepatide $399/mo, available in 49 states.
Read Full Review →Answer 6 quick questions about your health goals, budget, and insurance status. We'll match you with the program most likely to work for you.
Find Which Program Is Best For Your Budget →No email required. Results are immediate.